People living with HIV often worry about whether HIV is accelerating the aging process. HIV itself isn’t making many people ill, but some people with HIV are having problems with heart disease, cancers and brittle bones. These conditions — typically experienced as people get older ...

Dramatic decrease of funding from donors for HIV and TB responses and inability or unwillingness of governments to finance such programs has devastating effects on key affected populations (KAPs) in middle-income countries (MICs) – sex workers, men who have sex with men, people who use ...

A risk score based on routine assessments carried out during antenatal care in resource-limited settings can accurately predict which pregnant and breastfeeding women have an especially high risk of infection with HIV and would therefore benefit from pre-exposure prophylaxis (PrEP), investigators report in the online ...

Risk calculator developed by UCLA and Los Angeles LGBT Center may fill that void A new study from the UCLA Fielding School of Public Health suggests modifying federal health guidelines related to the use of pre-exposure prophylaxis to prevent HIV transmission because current standards could miss ...

Retroviruses – the family of viruses that includes HIV – are almost half a billion years old, according to new research by scientists at Oxford University. That’s several hundred million years older than previously thought and suggests retroviruses have ancient marine origins, having been with ...

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 218: Research with women and HIV, December 2016 issue is available at: http://www.catie.ca/en/treatmentupdate/treatmentupdate-218 Original Article

Vemlidy® is the first new treatment for chronic hepatitis B infection to be approved in the European Union in nearly a decade Gilead Sciences, Inc. (Nasdaq: GILD) announced that the European Commission has granted marketing authorization for Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet ...

Antiviral therapy could be improved with the newly uncovered atomic-level details LA JOLLA—Salk Institute scientists have solved the atomic structure of a key piece of machinery that allows HIV to integrate into human host DNA and replicate in the body, which has eluded researchers for decades. ...

Study identifies characteristics of HIV-1 strains that mediate sexual transmission PHILADELPHIA – Upon sexual exposure, the AIDS virus must overcome some mighty barriers to find the right target cell and establish a new infection. It must traverse the genital mucosa and squeeze through tightly packed epithelial ...

Smoking “dramatically” increases the risk of pregnancy loss – miscarriage or stillbirth – in HIV-positive women, US investigators report in the online edition of AIDS. Researchers from the large Women’s Interagency HIV Study (WIHS) examined the impact of smoking on pregnancy loss in HIV-positive and ...

CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus (HIV) infection, today announced the Company filed a request for Breakthrough Therapy Designation with the FDA for PRO 140 as a treatment for HIV-1 infection in treatment-experienced ...

Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine phase II clinical trial. The finding suggests that the therapy might be an effective ...

LONDON (Thomson Reuters Foundation) - One in seven people with HIV in the Europe Union region is unaware they have the virus, seriously hampering efforts to meet a global 2030 deadline for eradicating the AIDS epidemic, a senior health expert said on Tuesday. The average estimated ...

ELPA presents the stark findings of the 2016 Hep-CORE Report Berlin, 20 December 2016 – Fifty-two per cent (52%) of surveyed European (25) and Mediterranean Basin (2) countries lack national strategies to address viral hepatitis B or C despite the WHO World Health Assembly resolution calling ...

The mini pump could be key to eradicating a scourge in Africa. You don't have to wait until after an infection to fight HIV. A technique known as pre-exposure prophylaxis has you taking preemptive medicine on a regular basis, greatly reducing the chances that HIV will ...

MOSCOW, January 1. /TASS/. The Federal Register of HIV patients, set to be launched in Russia’s regions on January 1, will help provide patients with medicine, Health Ministry Spokesman Oleg Salagai told TASS. “Any individual diagnosed with HIV should be interested in being included in this ...

The success of recent local and state initiatives to end HIV as an epidemic will hinge on community mobilization efforts to inspire engagement in care and services, along with meaningful involvement at all levels of advocacy and policy, according to Community Mobilization: An Assessment of ...

Investigators claim VMMC scale-up plus 90-90-90 could end HIV, not just AIDS Scale-up of voluntary medical male circumcision (VMMC) in countries with a high HIV prevalence has the potential to reduce incidence of new infections over and above the level associated with attainment of the 90-90-90 ...